Multimodal prehabilitation didn’t show significant benefits for postoperative outcomes in a diverse surgical population. No notable reduction in major complications (adjusted risk ratio 1.02) or length of stay (adjusted incidence rate ratio 1.04). In high-risk GI oncological surgery patients, a non-significant 9% reduction in complications was observed. Surgeons should consider targeted prehabilitation for high-risk patients, […]

Colovac 2 may reduce the need for diverting ostomies after low anterior resection. 100% of Colovac devices were successfully placed and removed without complications. Only 8.3% experienced clinically significant migration, all retrieved successfully with no ostomy conversions. Surgeons can potentially avoid diverting ostomies in 87.5% of patients within 10 days post-surgery. 95.8% achieved fecal diversion […]

Neoadjuvant chemotherapy does not improve disease-free survival compared to upfront surgery for locally advanced colon cancer, but shows benefits in feasibility and reduced need for adjuvant therapy. Three-year disease-free survival: 87% for upfront surgery vs. 83% for neoadjuvant chemotherapy (p=0.36). Reduced requirement for adjuvant chemotherapy in the neoadjuvant group (59% vs 73%, p=0.02). Surgeons should […]

taTME shows promising long-term outcomes for low rectal cancer patients, crucial for surgical practice. Three-year overall survival was 93.7%, with disease-free survival at 84.6%. Late complications in 32 patients, with 21 classified as severe; one required surgical revision. Surgery can prioritize sphincter preservation without compromising oncologic outcomes. 97% of patients were stoma-free at three years, […]

High adherence to enhanced recovery program components can significantly cut costs in colorectal surgery. Patients with ≥70% adherence had total costs of $17,576 versus $22,343 for those with <70% adherence (p<0.001). Key cost-saving components included avoiding nasogastric tubes (-$16,036), early mobilization (-$3,476), and discontinuing maintenance intravenous fluids (-$4,460). Targeting specific ERP components could enhance outcomes […]

Antithrombotic therapy significantly increases the risk of anastomotic leakage after colorectal surgery, which is critical for patient management. 8.8% of patients developed anastomotic leakage, with antithrombotic therapy linked to a 2.10 times greater risk. Other risk factors include previous colorectal surgery (1.69 times), male sex (1.99 times), and anastomosis < 5 cm from the anal […]

A 3-stage redo ileal pouch-anal anastomosis significantly reduces pouch failure risk compared to a 2-stage approach. Redo pouch failure was 19.4% in the 3-stage group versus 32% in the 2-stage group (p=0.002). The 3-stage approach improved pouch survival (HR 0.68; p=0.04). Consider initial rediversion for patients with septic complications to enhance outcomes. Septic indications increased […]

Surgeons should note that higher surgical volume correlates with better outcomes in total mesorectal excision (TME) for rectal cancer. Facilities performing 16 or more TME annually were more likely to report TME grades (p=0.02). Robotic-assisted surgery achieved the highest complete TME rates (p<0.001) and lower conversion rates compared to laparoscopy (4.6% vs 14.6%, p<0.001). Complete […]